Implementation and utilization of genetic testing in personalized medicine

Area of Science:

• Genetics and Genomics
• Personalized Medicine
• Clinical Diagnostics

Background:

• Clinical genetic testing has evolved significantly over 30 years, from single gene mutation detection to genome-wide analyses.
• Historically focused on Mendelian disorders, genetic testing now includes common disease risk estimation and direct-to-consumer offerings.
• The integration of germline genetic risk with other variables forms the basis of personalized medicine.

Purpose of the Study:

• To review the current implementation of genetic testing for personalized medicine.
• To emphasize the role and current state of clinical pharmacogenetic testing.
• To discuss the challenges and opportunities in applying genetic information to patient care.

Main Methods:

• Review of advancements in molecular technologies for genetic testing.
• Analysis of the shift from Mendelian to common disease and pharmacogenetic testing.
• Discussion of the integration of genetic data into clinical assessment for personalized medicine.

Main Results:

• Genetic testing capabilities have expanded dramatically, enabling genome-wide analyses.
• The identification of DNA variants associated with common diseases has driven personalized medicine and direct-to-consumer testing.
• Pharmacogenetic testing, despite past adoption challenges, is emerging as a key component of personalized medicine due to technological advances.

Conclusions:

• Genetic testing is central to personalized medicine, aiming for precise medical management.
• Clinical utility and acceptance of genetic risk and pharmacogenetic testing remain areas of debate and development.
• Rapid advances in genetic testing technology are making preemptive genotyping and pharmacogenetics increasingly feasible in clinical settings.